Treatment Access, Health Economics, and the Wave of a Magic Wand

February 23rd, 2022|

From Current Oncology: "New drugs are expensive, in part due to excessive drug development costs. Governments are trying to reduce drug prices. This can delay access to effective agents. A country’s access to new drugs [...]

PMPRB: Why lower drug prices may mean less access

August 28th, 2021|

From Healthing: "The body responsible for pricing patented drugs in Canada — the Patented Medicine Prices Review Board (PMPRB) — has proposed changes to lower the cost of drugs, which are scheduled to come into [...]

The High Cost of Cheap

June 25th, 2021|

From C.A.R.P.: "Like father, like son. In the 1970s, Trudeau senior brought in price controls to combat inflation. They failed miserably. On July 1, Trudeau junior’s government will activate new Patented Medicines Price Review Board [...]

Letter to the Prime Minister

May 11th, 2021|

May 11, 2021 The Right Honourable Justin Trudeau, P.C., M.P. Prime Minister of Canada 80 Wellington St. Ottawa, ON, K1A 0A2 Subject: Delay and reconsider the PMPRB regulations Dear Prime Minister Trudeau, I am [...]

Let’s fight cancer like we’re fighting COVID-19

June 11th, 2020|

As we battle the pandemic, we should remember that cancer kills 7,000 Canadians every month and put the same effort into reducing that sad toll. In the three months since COVID-19 started shutting down the [...]

Go to Top